Recent CNIC News
Canadian Nuclear Isotope Council outlines ambitious vision to double Canada’s isotope production by 2030
Toronto – March 29, 2023 – The Canadian Nuclear Isotope Council (CNIC) launched its new Isotopes for Hope campaign at the Empire Club of Canada with the goal of asserting and expanding Canada’s...
The Canadian Nuclear Isotope Council Announces its Incorporation as a Not-for-Profit Organization
Toronto – February 24, 2023 – The Canadian Nuclear Isotope Council (CNIC) is pleased to announce its recent accomplishment in achieving Not-for-Profit status. In collaboration with the CNIC’s new...
ACIC Pharmaceutical Machinery Inc. joins the CNIC to help Canadian companies bring radiopharmaceutical products “from Molecule to Market”
Toronto – February 7, 2023 – ACIC Pharmaceutical Machinery, a Canadian company located in Brantford, ON, is the newest member of the Canadian Nuclear Isotope Council (CNIC). ACIC Machinery provides...
ARC Clean Technology and the Canadian Nuclear Isotope Council partner to bolster Canada’s Isotope Ecosystem
Toronto – December 20, 2022 – The Canadian Nuclear Isotope Council (CNIC) is pleased to announce a partnership with ARC Clean Technology (ARC). As a member of the CNIC, ARC joins 76+ organizations...
Canadian Nuclear Isotope Council: Statement Regarding the Worldwide Isotope Shortage
Toronto – November 10, 2022 – There is mounting concern in Canada and around the world that a global medical isotope shortage of Molybdenum-99 (Mo-99) is impacting patients. As a result, doctors...
AtomVie Global Radiopharma Inc. joins the CNIC to bring new leadership, innovation, and collaboration to the radiopharmaceutical industry.
Toronto – November 2, 2022 – AtomVie Global Radiopharma Inc. (AtomVie), a manufacturer and supplier of multiple finished-dose therapeutic radiopharmaceutical products, is the newest member of the...
Isotope Production System at Bruce Power commences Commercial Production of Lutetium-177
Toronto, Ontario – October 25, 2022 – Yesterday, the international partnership between Bruce Power, Isogen (a Kinectrics and Framatome company), and ITM Isotope Technologies Munich (ITM), announced...
BWXT Medical Submits Tc-99m Generator New Drug Application to FDA
Company Highlights Growing Nuclear Medicine Product Portfolio and Future Opportunities in Therapeutic Radioisotopes (OTTAWA, ON – September 13, 2022) – BWX Technologies, Inc. (NYSE: BWXT) announced...
The CNIC joins twenty leading organizations as part of a joint Industry Statement touting the benefits of nuclear isotopes.
Toronto – August 16, 2022 – The Canadian Nuclear Isotope Council (CNIC) is proud to participate in a joint Industry Statement to the Tenth Review Conference of the Parties to the Treaty on the...
BWXT Medical and TRIUMF Execute Agreement for Manufacture of High Purity Ac-225 Based Products
(OTTAWA, ON – June 13, 2022) – BWX Technologies, Inc. (NYSE: BWXT) announced today that subsidiary BWXT Medical Ltd. and TRIUMF, Canada’s particle accelerator centre, have executed a licensing and...
Job Posting: Policy, Government and Stakeholder Relations Specialist (Hybrid) – CLOSED
THIS POSITION IS NOW FILLED Job Overview Policy, Government and Stakeholder Relations Specialist at the CNIC is responsible for connecting federal, provincial, and municipal political leaders to the...
Laurentis is helping meet global demands by increasing He-3 production
Helium-3 (He-3) is a rare isotope used in research, border security and medical imaging In a world where raw materials and supplies are under tension, Helium-3 (He-3), a rare isotope used in quantum...
Installation complete of new Isotope Production System at Bruce Power, paving way for production of life-saving medical isotopes
TIVERTON, ON – January 24, 2022 – Bruce Power and Isogen (a partnership between Kinectrics and Framatome) have completed the installation of a groundbreaking Isotope Production System (IPS), making...
Laurentis Energy Partners signs long-term commercial agreement with Air Liquide for the distribution of Helium-3
Valuable isotope used in quantum computing, neutron research, border security and medical imaging Toronto, ON – Laurentis Energy Partners today announced a long-term commercial agreement with Air...
Regulatory approval supports Laurentis’s program to produce the medical isotope Molybdenum-99 in Ontario for BWXT Medical
One of the most prevalently used diagnostic imaging agents in nuclear medicine, helping to detect illnesses like cancer and heart disease Clarington, Ontario – A new program, led by Laurentis Energy...
Ontario Isotope Motion Passes Legislature Unanimously
November 2, 2021: Today in the Ontario legislature, a Private Member’s motion introduced by Bruce-Grey-Owen Sound MPP Bill Walker passed with all party support. The motion asserted Ontario’s global...
Laurentis Energy Partners: Strengthening Canada’s isotope leadership together
TORONTO – October 27, 2021 – Laurentis Energy Partners, an innovator and leader in the clean-energy industry, has joined the Canadian Nuclear Isotope Council (CNIC). Laurentis Energy Partners offers...
A historic day for Canada’s medical isotope industry
October 26, 2021: On Oct. 21, a historic Private Member’s Bill was introduced into the Legislature by Bill Walker, MPP for Bruce-Grey-Owen Sound. The bill asserted Ontario’s global role as a leader...
New Radioisotope for Cancer Therapy: A new Collaboration to produce copper-67
SASKATOON - Iotron Medical Inc. (Iotron) and Canadian Isotope Innovations Corp. (CIIC) are pleased to announce a collaboration to produce the radioisotope copper-67 (Cu-67) for new cancer therapies....
Storied Nuclear Manufacturer, Niagara Energy Products, joins the CNIC
TORONTO – August 24, 2021 – Niagara Energy Products (NEP), a leader in the field of manufacturing radiation shielded containment vessels for isotopes and nuclear contaminated waste, has joined the...
Publications
Canada has a unique position that is recognized globally: it is the world’s largest supplier of Cobalt-60 and Iodine-125; it hosts mostly all supply chain partners within its borders; it has a long tradition in supply chain collaboration; and it is renowned around the world for developing new applications.
Isotopes for Hope
Strengthening Canada’s Global Role in the Isotope Supply Chain to Double Production by 2030
Canadian Medical Isotope Ecosystem Directory
The Isotope Production Pipeline, its Suppliers and Associated Industries
Introduction to CNIC
A glance at this independent organization and its role to advocate for Canada’s role in the production of the world’s supply of isotopes.
Did You Know?
The Canadian Nuclear Safety Commission licenses the use and production of over 250 radioisotopes in Canada. And more key facts. . . .